With a robust background in healthcare investments, the fund manager has executed over 50 deals primarily in the life sciences and medical technology sectors. Active across North America and Europe, they have successfully navigated multiple investment stages, including growth equity and late-stage venture capital. Their operator-first strategy emphasizes collaboration with management teams, driving value through operational improvements. Noteworthy exits include several high-profile acquisitions, underscoring a strong track record in achieving significant returns.